Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study is to assess the efficacy of M2951 in participants with rheumatoid arthritis (RA) currently treated with stable dose of methotrexate (MTX).
Epistemonikos ID: 300ab2b87c0cc0781a2e8385cc710aa9789b3d00
First added on: Mar 23, 2022